Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1α is dominant negative

Diabetes

Volumn 47, Issue 8, 1998, Pages 1231-1235

  Yamagata, Kazuya ^a   Yang, Qin ^a   Yamamoto, Koji ^a   Iwahashi, Hiromi ^a   Miyagawa, Jun Ichiro ^a   Okita, Kohei ^a   Yoshiuchi, Issei ^a   Miyazaki, Jun Ichi ^a   Noguchi, Tamio ^b   Nakajima, Hiromu ^a   Namba, Mitsuyoshi ^a   Hanafusa, Toshiaki ^a   Matsuzawa, Ynji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; NUCLEAR FACTOR I; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DNA BINDING; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; MATURITY ONSET DIABETES MELLITUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ANIMALS; CELL LINE; COS CELLS; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FRAMESHIFT MUTATION; GENES, DOMINANT; HELA CELLS; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; MICE; NUCLEAR PROTEINS; RATS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0031848797     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.8.1231     Document Type: Article

References (26)

1. Fajans SS: Maturity-onset diabetes of the young. Diabetes Metab Rev 5:579-606, 1989
2. Byrne MM, Stuns J, Menzel S, Yamagata K, Fajans SS, Dronsfield MJ, Bain SC, Hattersley AT, Velho G, Froguel P, Bell GI, Polonsky KS: Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes mellitus susceptibility gene MODY3 on chromosome 12q. Diabetes 45:150:3-1510, 1996
3. Lehto M, Tuomi T, Mahtani M, Widen E, Forsblom C, Sarelin L, Gullstrom M, Isomaa B, Lehtovirta M, Hyrkko A, Kanninen T, Orho M, Manley S, Turner R, Brettin T, Kirby A, Thomas J, Duyk G, Lander E, Taskinen MR, Groop L: Characterization of the MODY3 diabetes. J Clin Invest 99:1-7, 1997
4. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj W, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Turner RC, Velho G, Chevre J-C, Froguel P, Bell GI: Mutations in the bepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 384:455-458, 1996
5. Mendel DB, Crabtree GR: HNF-1, a member of a novel class of dimerizing homeodomain proteins. J Biol Chem 266:677-680, 1991
6. Emens LA, Landers DW, Moss LG: Hepatocyte nuclear factor 1α is expressed in a hamster insulinoma line and transactivates the rat insulin I gene. Proc Natl Acad Sci USA 89:7300-7304, 1992
7. Takeda J, Kayano T, Fukumoto H, Bell GI: Organization of the human GLUT2 (pan- creatic β-cell and hepatocyte) glucose transporter gene. Diabetes 42:773-777, 1993
8. Vaulont S, Puzenat N, Levrat F, Cognet M, Kahn A, Raymondjean M: Proteins binding to the liver-specific pyruvate kinase gene promoter a unique combination of known factors. J Mol Biol 20:205-219, 1989
9. Noguchi T, Yamada K, Yamagata K, Takenaka M, Nakajima H, Imai E, Wang Z, Tanaka T: Expression of liver type pyruvate kinase in insulinoma cells: involvement of LF-B1 (HNF1). Biochem Biophys Res Commun 181:259-264, 1991
10. Miquerol L, Lopez S, Cartier N, Tulliez M, Raymonojean M, Kahn A: Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. J Biol Chem 269:8944-8951, 1994
11. Kaisaki PJ, Menzel S, Linder T, Oda N, Rjasanowki I, Sahm J, Meincke G, Schulze J, Schmechel H, Petzold C, Ledermann HM, Sachse G, Boriraj VV, Menzel R, Kerner W, Turner RC, Yamagata K, Bell GI: Mutations in the hepatocyte nuclear factor-la gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes 46:528-535, 1997
12. Frayling T, Bulman M, Ellard S, Appleton M, Dronsfield MJ, Mackie ADR, Baird JD, Kaisaki PJ, Yamagata K, Bell GI, Bain SC, Hattersley AT: Mutations in the hepatocyte nuclear factor-1α gene are a common cause of maturity-onset diabetes of the young in the United Kingdom. Diabetes 46:720-725, 1997
13. Glucksman MA, Lehto M, Tayber O, Scotti S, Berkemeier L, Pulido JC, Wu Y, Nir W-J, Fang L, Markel P, Munnelly KD, Goranson J, Orho M, Young BM, Whitacre JL, McMenimen C, Wantman M, Tuomi T, Warram J, Forsblom CM, Carlsson M, Rosenzweig J, Kennedy G, Duyk GM, Krolewski AS, Groop LC, Thomas JD: Novel mutations and a mutational hotspot in the MODY3 gene. Diabetes 46:1081-1086, 1997
14. Vaxillaire M, Rouard M, Yamagata K, Oda N, Kaisaki PJ, Boriraj W, Chevre J-C, Boccio V, Cox RD, Lathrop GM, Dussoix P, Philippe J, Timsit J, Charpentier G, Velho G, Bell GI, Froguel P: Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum Mol Genet 6:583-586, 1997
15. Gragnoli C, Lindner T, Cockburn BN, Kaisaki P, Gragnoli F, Marozzi G, Bell GI: Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4α binding site in the promoter of the hepatocyte nuclear factor-1α gene. Diabetes 46:1648-1651, 1997
16. Herskowitz I: Functional inactivation of genes by dominant negative mutations. Nature 329:219-222, 1987
17. D'Alessio D, Verchere CB, Kahn SE, Hoagland V, Baskin DG, Palmiter RD, Ensinck JW: Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes 43:1457-1461, 1994
18. Yamada K, Noguchi T, Miyazaki J, Matsuda T, Takenaka M, Yamamura K, Tanaka T: Tissue-specific expression of rat pyiuvate kinase L/chloramphenicol acetyltransferase fusion gene in transgenic mice and its regulation by diet and insulin. Biochem Biophys Res Commun 171:243-249, 1990
19. Yamada K, Noguchi T, Matsuda T, Takenaka M, Monad P, Nicosia A, Tanaka T: Identification and characterization of hepatocyte-specific regulatory regions of the rat pyruvate kinase L gene. J Biol Chem 265:19885-19891, 1990
20. Ishihara H, Asano T, Tsukuda K, Katagiri H, Inukai K, Anai M, Kikuchi M, Yazaki Y, Miyazaki J, Oka Y: Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets. Diabetologia 36:1139-1145, 1993
21. Nicosia A, Tafi R, Monaci P: Trans-dominant inhibition of transcription activator LFB1. Nucleic Acids Res 20:5321-5328, 1992
22. Cuif MH, Porteu A, Kahn A, Vaulont S: Exploration of a liver-specific, glucose/insulin-responsive promoter in transgenic mice. J Biol Chem 268:13769-13772, 1993
23. Sourdive DJD, Chouard T, Yaniv M: The HNF1 C-terminal domain contributes to transcriptional activity and modulates nuclear localisation. C R Acad Sci III 316:385-394, 1993
24. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF: Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 15:106-110, 1997
25. Stoffers DA, Ferrer J, Clarke WL, Habener JF: Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 17:138-139, 1997
26. Maquat LE: Defects in RNA splicing and the consequences of shortened translational reading frames. Am J Hum Genet 59:279-286, 1996